Cited 0 times in 
Cited 0 times in 
Effectiveness of single-pill combination olmesartan/amlodipine/hydrochlorothiazide therapy in patients with apparent resistant hypertension
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Oh, Jaewon | - |
| dc.contributor.author | Kim, Wonho | - |
| dc.contributor.author | Kim, Gee-Hee | - |
| dc.contributor.author | Kim, Hack-Lyoung | - |
| dc.contributor.author | Park, Sang-Don | - |
| dc.contributor.author | Min, Kyung Wan | - |
| dc.contributor.author | Hyun, Dongkeun | - |
| dc.contributor.author | Hong, Jun Hwa | - |
| dc.contributor.author | Lim, Soo | - |
| dc.contributor.author | Bae, Ji-Hwan | - |
| dc.contributor.author | Shin, Jinho | - |
| dc.date.accessioned | 2025-10-27T02:53:28Z | - |
| dc.date.available | 2025-10-27T02:53:28Z | - |
| dc.date.created | 2025-09-22 | - |
| dc.date.issued | 2025-09 | - |
| dc.identifier.issn | 0950-9240 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/207957 | - |
| dc.description.abstract | This pioneering study investigated the real-life effectiveness of single-pill combination (SPC) antihypertensive therapy in patients with uncontrolled blood pressure (BP) and cardiovascular risk factors. After treatment with olmesartan medoxomil/amlodipine besylate/hydrochlorothiazide for 24 weeks, adults with apparent resistant hypertension had significantly reduced systolic BP and approximately 80% achieved target BP. SPC therapy may improve adherence in patients with pseudo-resistant hypertension and is a potentially effective treatment for resistant hypertension. | - |
| dc.language | English | - |
| dc.publisher | Nature Publishing Group | - |
| dc.relation.isPartOf | JOURNAL OF HUMAN HYPERTENSION | - |
| dc.relation.isPartOf | JOURNAL OF HUMAN HYPERTENSION | - |
| dc.subject.MESH | Adult | - |
| dc.subject.MESH | Aged | - |
| dc.subject.MESH | Amlodipine* / administration & dosage | - |
| dc.subject.MESH | Amlodipine* / adverse effects | - |
| dc.subject.MESH | Amlodipine* / therapeutic use | - |
| dc.subject.MESH | Antihypertensive Agents* / administration & dosage | - |
| dc.subject.MESH | Antihypertensive Agents* / adverse effects | - |
| dc.subject.MESH | Antihypertensive Agents* / therapeutic use | - |
| dc.subject.MESH | Blood Pressure* / drug effects | - |
| dc.subject.MESH | Drug Combinations | - |
| dc.subject.MESH | Drug Resistance | - |
| dc.subject.MESH | Drug Therapy, Combination | - |
| dc.subject.MESH | Female | - |
| dc.subject.MESH | Humans | - |
| dc.subject.MESH | Hydrochlorothiazide* / administration & dosage | - |
| dc.subject.MESH | Hydrochlorothiazide* / adverse effects | - |
| dc.subject.MESH | Hydrochlorothiazide* / therapeutic use | - |
| dc.subject.MESH | Hypertension* / diagnosis | - |
| dc.subject.MESH | Hypertension* / drug therapy | - |
| dc.subject.MESH | Hypertension* / physiopathology | - |
| dc.subject.MESH | Imidazoles* / administration & dosage | - |
| dc.subject.MESH | Imidazoles* / therapeutic use | - |
| dc.subject.MESH | Male | - |
| dc.subject.MESH | Middle Aged | - |
| dc.subject.MESH | Olmesartan Medoxomil | - |
| dc.subject.MESH | Tetrazoles* / administration & dosage | - |
| dc.subject.MESH | Tetrazoles* / therapeutic use | - |
| dc.subject.MESH | Treatment Outcome | - |
| dc.title | Effectiveness of single-pill combination olmesartan/amlodipine/hydrochlorothiazide therapy in patients with apparent resistant hypertension | - |
| dc.type | Article | - |
| dc.contributor.googleauthor | Oh, Jaewon | - |
| dc.contributor.googleauthor | Kim, Wonho | - |
| dc.contributor.googleauthor | Kim, Gee-Hee | - |
| dc.contributor.googleauthor | Kim, Hack-Lyoung | - |
| dc.contributor.googleauthor | Park, Sang-Don | - |
| dc.contributor.googleauthor | Min, Kyung Wan | - |
| dc.contributor.googleauthor | Hyun, Dongkeun | - |
| dc.contributor.googleauthor | Hong, Jun Hwa | - |
| dc.contributor.googleauthor | Lim, Soo | - |
| dc.contributor.googleauthor | Bae, Ji-Hwan | - |
| dc.contributor.googleauthor | Shin, Jinho | - |
| dc.identifier.doi | 10.1038/s41371-025-01043-3 | - |
| dc.relation.journalcode | J01447 | - |
| dc.identifier.eissn | 1476-5527 | - |
| dc.identifier.pmid | 40659924 | - |
| dc.contributor.affiliatedAuthor | Oh, Jaewon | - |
| dc.identifier.scopusid | 2-s2.0-105015807235 | - |
| dc.identifier.wosid | 001528208900001 | - |
| dc.citation.volume | 39 | - |
| dc.citation.number | 9 | - |
| dc.citation.startPage | 675 | - |
| dc.citation.endPage | 678 | - |
| dc.identifier.bibliographicCitation | JOURNAL OF HUMAN HYPERTENSION, Vol.39(9) : 675-678, 2025-09 | - |
| dc.identifier.rimsid | 89554 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.type.docType | Article; Early Access | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
| dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.